Boston Scientific

U.S. multinational medical devices manufacturer

BSX NYSE ISIN US1011371077 SEC CIK 885725 LEI Y6ZDD9FP4P8JSSJMW954
Follow Boston Scientific Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $5.1B +1.4% vs same quarter last year
Net income $580M −23.2% vs same quarter last year
EPS, diluted $0.40 −21.6% vs same quarter last year
Operating cash flow $1B −22% vs same quarter last year
Revenue by quarter
$4.6B
$4.7B
$5.1B
$5.1B
$5.3B
$5.2B
$5.4B
$5.1B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$10B$0$10B$20B$30BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$20.1B$2.9B
FY24$16.7B$1.8B
FY23$14.2B$1.6B
FY22$12.7B$698M
FY21$11.9B$1B
FY20$9.9B−$82M
FY19$10.7B$4.7B
FY18$9.8B$1.7B
FY17$9B$104M
FY16$8.4B$347M
FY15$8.1B−$239M
FY14$7.5B−$119M
FY13$7.1B−$121M
FY12$7B−$4.1B
FY11$7.6B$441M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2569%18%14.4%
FY2468.6%15.5%11%
FY2369.5%16.5%11.2%
FY2268.8%13%5.5%
FY2168.8%10.1%8.8%
FY2065%−0.8%−0.8%
FY1971%14.1%43.8%
FY1871.4%15.3%17%
FY1771.3%14.2%1.1%
FY1671.1%5.3%4.1%
FY1565.7%−3.5%−3%
FY1469.3%−4%−1.6%
FY1370.3%1.7%−1.7%
FY1270.4%−55.6%−58.5%
FY1165.1%11.9%5.8%
Free cash flowOperating cash flow minus capital expenditure
−$1B$0$1B$2B$3B$4BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$3.7B
FY24$2.6B
FY23$1.8B
FY22$938M
FY21$1.3B
FY20$1.1B
FY19$1.4B
FY18−$6M
FY17$1.1B
FY16$806M
FY15$444M
FY14$1B
FY13$865M
FY12$1.1B
FY11$704M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25--
FY24$0-
FY23$28M-
FY22$55M$0
FY21$55M$0
FY20$28M$535M
FY19$0$0
FY18$0$0
FY17--
FY16-$0
FY15-$0
FY14-$125M
FY13-$500M
FY12-$600M
FY11-$492M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Boston Scientific
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBoston ScientificHealthcare median
FY2514.4%−30.6%
FY2411%−47%
FY2311.2%−58%
FY225.5%−80.4%
FY218.8%−71.9%
FY20−0.8%−62.2%
FY1943.8%−46.3%
FY1817%−49.6%
FY171.1%−45.9%
FY164.1%−36%
FY15−3%−38.4%
FY14−1.6%−35.5%
FY13−1.7%−37.1%
FY12−58.5%−29.1%
FY115.8%−27.9%